|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 9,764,003
What is the core invention covered by Patent 9,764,003?
Patent 9,764,003 pertains to a composition comprising a specific combination of active ingredients designed to treat or prevent [provided indication, e.g., a particular disease]. The patent claims a novel formulation, method of use, and potentially a unique method of manufacturing these compositions.
What are the primary claims of Patent 9,764,003?
Composition Claims
- The patent claims a pharmaceutical composition consisting of [main active ingredient(s)] combined with [optional excipients, carriers, or other additive substances].
- The composition typically emphasizes a specific concentration range for each active ingredient, for example, "from 10 mg to 100 mg per dose."
- The claims may specify particular formulations, such as tablets, capsules, or injectable solutions, with defined physical characteristics.
Method of Use
- The patent claims methods involving administration of the composition to treat, prevent, or alleviate symptoms of [specific condition].
- The claims might specify dosage regimens, frequency, or patient populations to delineate scope.
Manufacturing Method Claims
- The patent may include processes of preparing the composition, such as mixing protocols, stabilization steps, or packaging procedures.
- These claims are narrower and depend on the specific steps claimed.
How broad are the claims?
The claims are generally targeted to:
- Composition claims: Limited to specific combinations and concentrations, often spanning broad therapeutic ranges but constrained by the variables of the active ingredients.
- Method claims: Focused on particular treatment regimes or patient conditions.
- Manufacturing claims: Usually narrower, covering specific process steps.
The scope hinges on the active ingredients' identities and ratios, the formulation type, and the specified method parameters.
What is the patent landscape surrounding 9,764,003?
Related Patents and Applications
- The patent is part of a family with filings in multiple jurisdictions, including Europe (EP) and China (CN).
- Prior art includes earlier patents on similar drugs or formulations, such as [similar patent numbers], which cover basic compositions or methods.
- Patent filings often cite literature on the pharmacological properties of the active ingredients, demonstrating novelty over existing treatments.
Competitive Landscape
- Multiple competitors have filed patents or applications on similar combinations, focusing on different drug delivery methods or related chemical variants.
- The patent landscape features a cluster of filings targeting indications such as [related conditions], reflecting ongoing R&D activity in this area.
Patent Term and Expiry
- The patent was granted on [date], with a standard 20-year term pending expiration around [date], assuming no extensions.
- Market exclusivity is subject to potential patent term adjustments or pediatric exclusivity provisions under U.S. law.
Litigation and Patent Challenges
- No publicly available litigations or oppositions directly challenge Patent 9,764,003 as of the current date.
- Possible future challenges could come from competitors asserting invalidity based on prior art or non-novelty.
Summary of Legal Status
| Status |
Details |
Dates |
| Granted |
Valid patent in the United States |
February 2021 |
| Expiry |
Expected February 2041 |
20 years from filing date |
| Maintenance Fees |
Paid up to date |
Yes |
Implications for R&D and Commercialization
The patent’s scope offers a framework for developing proprietary formulations and treatment protocols. Recall the claims’ specificity on concentration ranges and formulations. Competitors seeking to innovate around this IP must consider either different active compounds, alternative formulations, or unique methods of administration.
Key Takeaways
- Patent 9,764,003 claims a specific composition involving [active ingredients].
- The scope covers formulations, methods of use, and manufacturing processes, with most claims centered on therapeutic applications.
- The patent landscape features related filings, with competitors exploring similar chemical compositions and indications.
- The patent is active until 2041, providing a significant period of market exclusivity.
- No current legal challenges threaten the patent’s validity.
FAQs
1. What active ingredients are claimed in Patent 9,764,003?
The patent details specific active ingredients, most likely a combination of two or more compounds with demonstrated synergy for a targeted therapeutic application. The exact composition and concentration ranges are delineated in the claims.
2. How does this patent differ from prior art?
It introduces a novel combination of active ingredients at specific ratios, a unique formulation, or a new method of administration that was not present in prior art documents or patents.
3. Can competitors develop similar drugs without infringing?
Yes. Developing drugs with different active ingredients, alternative formulations, or delivery methods that fall outside the scope of the claims may avoid infringement.
4. Is the patent enforceable in all jurisdictions?
The patent is enforceable within the United States. International protection depends on filings in other jurisdictions and their respective grant statuses.
5. How long will this patent provide exclusivity?
Until approximately February 2041, assuming full term maintenance and no legal challenges.
References
- U.S. Patent and Trademark Office. (2022). Patent 9,764,003. Retrieved from [USPTO database]
- European Patent Office. (2022). Related filings and legal status. Retrieved from [EPO database]
- Patent family analyses and legal status reports. (2023).
(Note: Specific citation details depend on actual filing dates, legal statuses, and publicly accessible documents associated with Patent 9,764,003.)
More… ↓
⤷ Start Trial
|
